Analystreport

Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $32.00 price t

Dicerna Pharmaceuticals, Inc.  (DRNA) 
Last dicerna pharmaceuticals, inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.dicerna.com